Because TOP2B is essential for all AR isoforms to initiate transcription even after they are activated and recruited to targeted promoters under antiandrogen treatment conditions, blocking TOP2B serves as a new approach to inhibit both AR and AR-driven PCa growth. The gene discussed is AR; the disease is posterior cortical atrophy.